|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.88 USD | +1.36% |
|
+0.31% | +11.12% |
| May. 15 | Mubadala Investment Co PJSC raises share stake in AbbVie, Match Group, cuts in CVS Health | RE |
| May. 06 | UBS Adjusts Price Target on Match to $38 From $34, Maintains Neutral Rating | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2.98B | 3.19B | 3.36B | 3.48B | 3.49B | |||||
Total Revenues | 2.98B | 3.19B | 3.36B | 3.48B | 3.49B | |||||
Cost of Goods Sold, Total | 837M | 958M | 952M | 989M | 946M | |||||
Gross Profit | 2.15B | 2.23B | 2.41B | 2.49B | 2.54B | |||||
Selling General & Admin Expenses, Total | 976M | 973M | 1B | 1.06B | 1.04B | |||||
Stock-Based Compensation (IS) | - | - | - | - | - | |||||
R&D Expenses | 241M | 334M | 384M | 442M | 450M | |||||
Depreciation & Amortization - (IS) | 41.4M | 43.59M | 61.81M | 87.5M | 67.11M | |||||
Amortization of Goodwill and Intangible Assets - (IS) | 28.56M | 366M | 47.73M | 43.58M | 38.55M | |||||
Other Operating Expenses, Total | 1.29B | 1.72B | 1.5B | 1.64B | 1.59B | |||||
Operating Income | 859M | 515M | 917M | 854M | 947M | |||||
Interest Expense, Total | -130M | -146M | -160M | -160M | -148M | |||||
Interest And Investment Income | - | 4.4M | 26.8M | 41.1M | 21.94M | |||||
Net Interest Expenses | -130M | -141M | -133M | -119M | -126M | |||||
Currency Exchange Gains (Loss) | -1.8M | -2M | -7.9M | -579K | -8.32M | |||||
Other Non Operating Income (Expenses) | -22.24M | 2.13M | 872K | 289K | 7.41M | |||||
EBT, Excl. Unusual Items | 705M | 374M | 777M | 735M | 821M | |||||
Restructuring Charges | - | - | - | - | - | |||||
Merger & Related Restructuring Charges | -7.5M | - | - | - | - | |||||
Impairment of Goodwill | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | - | -30.6M | - | |||||
Legal Settlements | -441M | 3.5M | - | - | -74.5M | |||||
Other Unusual Items | - | - | - | - | -9.9K | |||||
EBT, Incl. Unusual Items | 256M | 377M | 777M | 704M | 746M | |||||
Income Tax Expense | -19.9M | 15.36M | 125M | 153M | 133M | |||||
Earnings From Continuing Operations | 276M | 362M | 651M | 551M | 613M | |||||
Earnings Of Discontinued Operations | 509K | -2.21M | - | - | - | |||||
Net Income to Company | 277M | 360M | 651M | 551M | 613M | |||||
Minority Interest | 1.17M | 2.03M | 67K | -37K | -15K | |||||
Net Income - (IS) | 278M | 362M | 652M | 551M | 613M | |||||
Net Income to Common Incl Extra Items | 278M | 362M | 652M | 551M | 613M | |||||
Net Income to Common Excl. Extra Items | 277M | 364M | 652M | 551M | 613M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 1.01 | 1.28 | 2.36 | 2.12 | 2.53 | |||||
Basic EPS - Continuing Operations | 1.01 | 1.29 | 2.36 | 2.12 | 2.53 | |||||
Basic Weighted Average Shares Outstanding | 275M | 283M | 276M | 260M | 243M | |||||
Net EPS - Diluted | 0.93 | 1.24 | 2.26 | 2.02 | 2.38 | |||||
Diluted EPS - Continuing Operations | 0.93 | 1.25 | 2.26 | 2.02 | 2.38 | |||||
Diluted Weighted Average Shares Outstanding | 305M | 295M | 293M | 279M | 262M | |||||
Normalized Basic EPS | 1.61 | 0.83 | 1.76 | 1.76 | 2.11 | |||||
Normalized Diluted EPS | 1.45 | 0.8 | 1.66 | 1.65 | 1.95 | |||||
Dividend Per Share | - | - | - | 0.19 | 0.76 | |||||
Payout Ratio | - | - | - | - | 30.36 | |||||
American Depositary Receipts Ratio (ADR) | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | |||||
Supplemental Items | ||||||||||
EBITDA | 929M | 925M | 1.03B | 985M | 1.05B | |||||
EBITA | 888M | 881M | 965M | 897M | 986M | |||||
EBIT | 859M | 515M | 917M | 854M | 947M | |||||
EBITDAR | 957M | 952M | 1.05B | 1.01B | 1.08B | |||||
Effective Tax Rate - (Ratio) | -7.77 | 4.07 | 16.13 | 21.69 | 17.77 | |||||
Current Domestic Taxes | 3.21M | 9.77M | 70.66M | 125M | 41.05M | |||||
Current Foreign Taxes | 34.86M | 35.54M | 28.04M | 43.15M | 46.55M | |||||
Total Current Taxes | 38.07M | 45.31M | 98.7M | 168M | 87.61M | |||||
Deferred Domestic Taxes | -51.35M | 82.26M | 32.6M | -8.59M | 42.2M | |||||
Deferred Foreign Taxes | -6.62M | -112M | -5.99M | -6.36M | 2.73M | |||||
Total Deferred Taxes | -57.97M | -29.95M | 26.61M | -14.95M | 44.94M | |||||
Normalized Net Income | 442M | 236M | 486M | 459M | 513M | |||||
Interest on Long-Term Debt | 25.55M | 19.86M | 19.13M | 19.17M | 19.09M | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | - | - | 520M | 547M | 550M | |||||
Marketing Expenses | 510M | 475M | - | - | - | |||||
Selling and Marketing Expenses | 566M | 535M | 586M | 622M | 626M | |||||
General and Administrative Expenses | 382M | 411M | 390M | 413M | 387M | |||||
Research And Development Expense From Footnotes | 241M | 334M | 384M | 442M | 450M | |||||
Net Rental Expense, Total | 27.4M | 26.74M | 25.61M | 27.72M | 26.99M | |||||
Imputed Operating Lease Interest Expense | 7.16M | 7.78M | 8.29M | 8.97M | 7.92M | |||||
Imputed Operating Lease Depreciation | 20.24M | 18.96M | 17.32M | 18.74M | 19.07M | |||||
Stock-Based Comp., COGS (Total) | 5.55M | 5.9M | 5.93M | 7.02M | 6.5M | |||||
Stock-Based Comp., R&D Exp. (Total) | 51.9M | 84.24M | 118M | 144M | 150M | |||||
Stock-Based Comp., S&M Exp. (Total) | 7.94M | 7.61M | 9.73M | 12.62M | 11.66M | |||||
Stock-Based Comp., G&A Exp. (Total) | 81.42M | 106M | 98.51M | 104M | 90.4M | |||||
Stock-Based Comp., Other (Total) | - | - | - | - | - | |||||
Total Stock-Based Compensation | 147M | 204M | 232M | 267M | 258M |
- Stock Market
- Equities
- MTCH Stock
- Financials Match Group, Inc.
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















